Cargando…

Dosimetric comparison of graphical optimization and inverse planning simulated annealing for brachytherapy of cervical cancer

PURPOSE: Graphical optimization (GO) and inverse planning simulated annealing (IPSA) are the main treatment planning optimization techniques used in patients undergoing 3D brachytherapy treatment. This study aims to compare the dosimetric difference of plans optimized by GO and IPSA in cervical canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bin, Liu, Xiangyu, Wang, Xianliang, Kang, Shengwei, Wang, Pei, Li, Jie, Orlandini, Lucia Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737576/
https://www.ncbi.nlm.nih.gov/pubmed/31523240
http://dx.doi.org/10.5114/jcb.2019.87145
Descripción
Sumario:PURPOSE: Graphical optimization (GO) and inverse planning simulated annealing (IPSA) are the main treatment planning optimization techniques used in patients undergoing 3D brachytherapy treatment. This study aims to compare the dosimetric difference of plans optimized by GO and IPSA in cervical cancer brachytherapy. MATERIAL AND METHODS: 21 cervical cancer patients data sets consisted of computed tomography (CT) and magnetic resonance imaging (MRI), acquired with the Fletcher applicator in situ were transferred to the Oncentra brachytherapy planning system. For each patient, the treatment plan was initially optimized with GO to reach a maximal D(90) tumor dose (6 Gy/fraction, 5 fractions), while keeping the dose to organs at risk (OARs) as low as possible. A second plan was then optimized with IPSA on the same CT images and data set (i.e., contours, catheters, and location of dwell points). Targets and OARs dose volume histograms and irradiation time were compared; data were analyzed with paired t-test; p value < 0.05 was considered statistically significant. RESULTS: The plans with both optimizations meet the clinical requirements. The mean D(90) of the clinical target volume was comparable for GO and IPSA. Similar values (p > 0.05) of target V(100), V(150), V(200), HI, and CI were registered for GO and IPSA optimizations. Bladder and rectum D(1cc) and D(2cc) obtained by GO resulted in larger values than those obtained by IPSA (p = 0.002). V(75) for bladder and rectum were slightly higher for IPSA, but without statistical difference (p > 0.05). The irradiation time was comparable (p > 0.05). CONCLUSIONS: In 3D brachytherapy of cervical cancer, GO and IPSA optimizations do not present a significant difference in target dose coverage; nevertheless, IPSA may reduce the maximum dose to normal tissue when compared with GO.